This topic contains a solution. Click here to go to the answer

Author Question: A woman is interested in the transdermal contraceptive patch. She is 5'5 tall and weighs 200 lb ... (Read 88 times)

elizabeth18

  • Hero Member
  • *****
  • Posts: 559
A woman is interested in the transdermal contraceptive patch. She is 5'5 tall and weighs 200 lb (90.9 kg). What information should the nurse provide this patient as a priority?
 
  A.
  It may cause skin irritation.
  B.
  She can't use the patch at her weight.
  C.
  The patch is about 95 effective.
  D.
  Withdrawal bleeding occurs monthly.

Question 2

The clinic nurse is counseling a woman who had a Nexplanon rod implanted. The nurse reminds her that she will need an appointment to replace this birth control method in what time frame?
 
  A.
  12 months
  B.
  24 months
  C.
  36 months
  D.
  48 months



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

shaquita

  • Sr. Member
  • ****
  • Posts: 324
Answer to Question 1

ANS: B
All answers are correct; however, because this woman is obese, the nurse needs to tell her that women weighing over 198 lb should not use the patch. This is because of concerns that excessive adipose tissue may be associated with inconsistent levels of hormonal absorption.

Answer to Question 2

ANS: C
Nexplanon is a subdermal contraceptive that must be removed and replaced every 3 years if continued contraception is desired. The single-rod implant, which is inserted on the inner side of the woman's upper arm, contains etonogestrel, which is a progestin.




elizabeth18

  • Member
  • Posts: 559
Reply 2 on: Jun 28, 2018
Wow, this really help


daiying98

  • Member
  • Posts: 354
Reply 3 on: Yesterday
Excellent

 

Did you know?

There are 60,000 miles of blood vessels in every adult human.

Did you know?

Medication errors are three times higher among children and infants than with adults.

Did you know?

There are more sensory neurons in the tongue than in any other part of the body.

Did you know?

More than 150,000 Americans killed by cardiovascular disease are younger than the age of 65 years.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library